Core Points - The White House announced the launch of a direct-to-consumer website called "TrumpRx" for purchasing discounted prescription drugs directly from the federal government [1] - The initiative aims to increase transparency, with prices reportedly being 80% lower than current prices [1] - The website is expected to eliminate the need for consumers to purchase drugs from Canada, allowing them to buy from home [1] Group 1: Market Impact - Health economist Craig Garthwaite expressed skepticism about the potential market impact, noting that most consumers require insurance for expensive drugs and that prices may not be lower than net prices or out-of-pocket payments [2] - The White House has reached an agreement with Pfizer to sell its drugs to Medicaid at lower prices, indicating a direct collaboration with major pharmaceutical companies [2] Group 2: Regulatory Actions - In May, an executive order was signed by President Trump to pressure pharmaceutical companies to offer drugs at "Most Favored Nation status," which is based on the lowest price available in comparable countries [3] - Following the executive order, Trump sent letters to Pfizer's CEO and other major drugmakers, demanding price reductions within a 60-day compliance period [3]

美国政府停摆"黑天鹅" 大家好，10月的第一天，你们都出发了吗？路上肯定很堵吧，一起看看今晚海外市场的表现。 美股震荡 9月30日晚间，美股三大指数集体下跌，背后原因是美国政府面临关门危机。 分析师表示："就华盛顿而言，市场普遍预期关门会发生，所以投资者目前基本按兵不动，但如果持续超过两周，人们会开始更加担心。" 野村发达市场首席经济学家大卫·塞夫表示，政府关门至少不会改变美联储在10月份即将召开的会议上的决定。公布的数据越少，美联储 就越没有理由偏离点阵图，点阵图显示10月份调整25个基点。"无论他们是否拿到数据，我们的观点都是，这一举措都会发生。" 分析指出，随着美国政府停摆的可能性上升，股市震荡加剧，市场担忧停摆会持续多久，以及关键经济数据可能延迟发布将如何影响美联 储即将到来的利率决策。 尽管政府关门通常不会显著推动市场波动，但这一次可能不同，因为投资者已对劳动力市场放缓、滞胀风险和偏高的股票估值保持警惕。 关门还可能促使评级机构重新评估美国信用状况，穆迪已在5月下调过评级。 众议院议长、路易斯安那州共和党人迈克·约翰逊表示，他对能否在午夜最后期限前避免关门"持怀疑态度"，称结果取决于参议院少数党 领 ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

【导读】 美国政府停摆"黑天鹅" 中国基金报记者 泰勒 大家好，10月的第一天，你们都出发了吗？路上肯定很堵吧，一起看看今晚海外市场的表现。 美股震荡 众议院议长、路易斯安那州共和党人迈克·约翰逊表示，他对能否在午夜最后期限前避免关门"持怀疑态度"，称结果取决于参议院少 数党领袖、纽约州民主党人查克·舒默和众议院少数党领袖、纽约州民主党人哈基姆·杰弗里斯。杰弗里斯则表示，关于共和党 人，"如果政府关门，那是他们做出的决定" 。 如果美国政府最终暂停运作，劳工部表示，原定于周五发布的9月非农就业报告将不会公布。该报告是多项即将发布的重要数据之 一，这些数据将在美联储10月政策会议前为美国经济走向提供关键信息。周二公布的最新消费者信心读数低于预期。 Natixis投资管理公司的首席投资策略师杰克·雅纳西维奇表示："投资者对劳动力市场走弱的风险高度敏感，同时也密切关注关税向 通胀传导的迹象。任何因关门导致的经济数据收集延迟都可能带来不确定性上升。而随着不确定性上升，我们往往会看到金融市场波 动性加大。" 他补充道："这种不确定性会不会大到损害经济背景并连带打击风险资产？可能不会产生持久影响，但不确定性拖得越久，风险 ...

Well, we are expecting the president to announce a drug pricing deal with Fizer any minute now. That's according to two people familiar with those plans. Now, we're looking for three things in particular, and that's according to one person familiar with what we're expecting. So, first, we're expecting that Fiser will agree to lower prices in Medicaid.We're also expecting a three-year exemption from tariffs on the condition that Fizer builds more in the US. And the third thing is that Fizer will agree to sel ...

may have noticed uh some of the pharmaceutical names have moved up sharply in the last few minutes. We've got some breaking news out of Washington on drug pricing. Aean Jabers has the details perhaps filling us in on why we've seen this move.Aean. Yeah, David. It is pharmaceutical related.Uh and we don't have all the details right now. We're trying to solve a mystery in real time here, which is that the president has an event on his calendar at 11:00 a. m.just scheduled as an announcement. Uh and the questi ...

Core Points - The announcement from the White House is related to pharmaceutical pricing, specifically involving a deal with a major pharmaceutical company [3][4][5] - The agreement reportedly includes discounted prices for Medicaid and a three-year reprieve on tariffs for products manufactured in the United States [3][5] - The company involved in the deal is speculated to be Pfizer, although this has not been officially confirmed by the White House [4][5][7] Pharmaceutical Industry Impact - The initiative aims to lower drug prices across the board, aligning with the president's goal to address pharmaceutical pricing as a significant issue during his presidency [5] - The program may be branded as "Trump RX," allowing consumers to purchase certain medications directly from a government website [6][7] - There is uncertainty regarding the participation of other pharmaceutical companies and the implications for individuals already on Medicare or Medicaid [7]

Core Viewpoint - Pfizer announced an acquisition of Metsera, offering $47.50 per share, with an additional $22.50 per share contingent on the achievement of specific drug milestones [1] Company Summary - Pfizer is set to pay a total of $70 per share for Metsera if certain performance milestones are met, indicating a strategic investment in Metsera's drug pipeline [1]

Market Initiatives - President Trump plans to unveil a direct-to-consumer website for Americans to buy drugs, dubbed TrumpRx [1] Pharmaceutical Pricing - Pfizer plans to lower prices on several of its medications in the US [1] Source of Information - White House press secretary Karoline Leavitt announced the plan on X [1]

President Donald Trump on Tuesday announces an agreement with Pfizer to voluntarily sell its medications at lower prices, as his administration pushes to link U.S. drug prices to the cheaper prices paid abroad. Pfizer CEO Albert Bourla will be in attendance, a White House official said. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on ...